Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Gastric Cancer

Free Subscription Articles published in Anticancer Res Retrieve available abstracts of 70 articles: HTML format Text format

Single Articles

January 2010
1. TAHARA T , Shibata T, Arisawa T, Nakamura M, et al
   CpG Island Promoter Methylation (CIHM) Status of Tumor Suppressor Genes Correlates with Morphological Appearances of Gastric Cancer.
   Anticancer Res. 2010;30:239-44.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. HIBI K , Sakata M, Sakuraba K, Kitamura YH, et al
   Methylation of the DCC Gene Is Lost in Advanced Gastric Cancer.
   Anticancer Res. 2010;30:107-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
3. HIBI K , Sakata M, Yokomizo K, Kitamura YH, et al
   Methylation of the MGMT gene is frequently detected in advanced gastric carcinoma.
   Anticancer Res. 2009;29:5053-5.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. SZAFLARSKA A , Szczepanik A, Siedlar M, Czupryna A, et al
   Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer.
   Anticancer Res. 2009;29:5005-12.
   PubMed     Text format     Related articles    Abstract available
   
   
   November 2009
5. IWASA S , Yanagawa T, Fan J, Katoh R, et al
   Expression of CXCR4 and its Ligand SDF-1 in Intestinal-type Gastric Cancer Is Associated with Lymph Node and Liver Metastasis.
   Anticancer Res. 2009;29:4751-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. NASHIMOTO A , Yabusaki H, Nakagawa S, Takii Y, et al
   Preoperative chemotherapy with s-1 and Cisplatin for highly advanced gastric cancer.
   Anticancer Res. 2009;29:4689-96.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. WARNECKE-EBERZ U , Bollschweiler E, Drebber U, Metzger R, et al
   Prognostic Impact of Protein Overexpression of the Proto-oncogene PIM-1 in Gastric Cancer.
   Anticancer Res. 2009;29:4451-5.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. HIBI K , Sakata M, Sakuraba K, Kitamura YH, et al
   Changes in UNC5C Gene Methylation during Human Gastric Carcinogenesis.
   Anticancer Res. 2009;29:4397-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. PECTASIDES D , Psyrri A, Pliarchopoulou K, Floros T, et al
   Gastric metastases originating from breast cancer: report of 8 cases and review of the literature.
   Anticancer Res. 2009;29:4759-63.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. BECHTEL W , Bauer G
    Modulation of intercellular ROS signaling of human tumor cells.
    Anticancer Res. 2009;29:4559-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. CHOI WY , Jin CY, Han MH, Kim GY, et al
    Sanguinarine sensitizes human gastric adenocarcinoma AGS cells to TRAIL-mediated apoptosis via down-regulation of AKT and activation of caspase-3.
    Anticancer Res. 2009;29:4457-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
12. KATSUBE T , Murayama M, Isohata N, Asaka S, et al
    The Efficacy of Endoscopic Submucosal Dissection Compared with Modified Endoscopic Aspiration Mucosectomy by Assessing the Short-term Therapeutic Results for Differentiated Mucosal Gastric Cancer.
    Anticancer Res. 2009;29:4271-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. TAHARA T , Shibata T, Nakamura M, Yamashita H, et al
    RANTES Promoter Genotype and Gastric Cancer Risk in a Japanese Population.
    Anticancer Res. 2009;29:4265-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. YAMAMOTO K , Fujiwara Y, Nishida T, Takiguchi S, et al
    Induction Chemotherapy with Docetaxel, 5-FU and CDDP (DFP) for Advanced Gastric Cancer.
    Anticancer Res. 2009;29:4211-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. KODERA Y , Nakanishi H, Ito S, Misawa K, et al
    Expression of L1 Cell Adhesion Molecule Is a Significant Prognostic Factor in pT3-stage Gastric Cancer.
    Anticancer Res. 2009;29:4033-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. HIBI K , Kitamura YH, Mizukami H, Goto T, et al
    Frequent CDH3 Demethylation in Advanced Gastric Carcinoma.
    Anticancer Res. 2009;29:3945-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. LEGAKIS I , Stathopoulos J, Matzouridis T, Stathopoulos GP, et al
    Decreased plasma ghrelin levels in patients with advanced cancer and weight loss in comparison to healthy individuals.
    Anticancer Res. 2009;29:3949-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
18. CHARALABOPOULOS K , Kotsalos A, Batistatou A, Charalabopoulos A, et al
    Serum and tissue selenium levels in gastric cancer patients and correlation with CEA.
    Anticancer Res. 2009;29:3465-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. FUJITANI K , Tsujinaka T, Yamasaki H, Hirao M, et al
    Feasibility study of S-1 plus weekly docetaxel combined with concurrent radiotherapy in advanced gastric cancer refractory to first-line chemotherapy.
    Anticancer Res. 2009;29:3385-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. SASADA S , Ninomiya M, Nishizaki M, Harano M, et al
    Frequency of lymph node metastasis to the splenic hilus and effect of splenectomy in proximal gastric cancer.
    Anticancer Res. 2009;29:3347-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
21. MATSUDA G , Kunisaki C, Makino H, Fukahori M, et al
    Phase II Study of Weekly Paclitaxel as a Second-line Treatment for S-1-refractory Advanced Gastric Cancer.
    Anticancer Res. 2009;29:2863-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. TSUTANI Y , Ohara M, Suzuki T, Minami K, et al
    Docetaxel and S-1 as a First-line Treatment in Patients with Advanced or Recurrent Gastric Cancer.
    Anticancer Res. 2009;29:2775-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. OBA K , Kobayashi M, Matsui T, Kodera Y, et al
    Individual Patient Based Meta-analysis of Lentinan for Unresectable/Recurrent Gastric Cancer.
    Anticancer Res. 2009;29:2739-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. SAKAKURA C , Hamada T, Miyagawa K, Nishio M, et al
    Quantitative Analysis of Tumor-derived Methylated RUNX3 Sequences in the Serum of Gastric Cancer Patients.
    Anticancer Res. 2009;29:2619-2625.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. CALCAGNO DQ , Guimaraes AC, Leal MF, Seabra AD, et al
    MYC insertions in diffuse-type gastric adenocarcinoma.
    Anticancer Res. 2009;29:2479-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
26. SAKATA M , Kitamura YH, Sakuraba K, Goto T, et al
    Methylation of HACE1 in Gastric Carcinoma.
    Anticancer Res. 2009;29:2231-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. KITAMURA YH , Shirahata A, Sakata M, Goto T, et al
    Frequent Methylation of Vimentin in Well-differentiated Gastric Carcinoma.
    Anticancer Res. 2009;29:2227-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. KAIZAKI R , Yashiro M, Shinto O, Yasuda K, et al
    Expression of ERas Oncogene in Gastric Carcinoma.
    Anticancer Res. 2009;29:2189-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. KONISHI H , Kikuchi S, Ochiai T, Ikoma H, et al
    Latrunculin a has a strong anticancer effect in a peritoneal dissemination model of human gastric cancer in mice.
    Anticancer Res. 2009;29:2091-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. KI MR , Hong IH, Park JK, Hong KS, et al
    Potent neutralization of vacuolating cytotoxin (VacA) of Helicobacter pylori by immunoglobulins against the soluble recombinant VacA.
    Anticancer Res. 2009;29:2393-402.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
31. BABA E , Fujishima H, Kusaba H, Esaki T, et al
    Phase I study of the sequential administration of s-1 and Cisplatin for metastatic gastric cancer.
    Anticancer Res. 2009;29:1727-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. BAR-SELA G , Tsalic M, Steiner M, Wollner M, et al
    Local recurrence following adjuvant chemotherapy without radiotherapy in completely resected stomach and gastroesophageal junction adenocarcinoma.
    Anticancer Res. 2009;29:1853-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
33. YAMASAKI A , Shoda M, Iijima H, Nagai S, et al
    A Protein-bound Polysaccharide, PSK, Enhances Tumor Suppression Induced by Docetaxel in a Gastric Cancer Xenograft Model.
    Anticancer Res. 2009;29:843-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
34. TSAMANDAS AC , Kardamakis D, Tsiamalos P, Liava A, et al
    The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
    Anticancer Res. 2009;29:703-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. TAHARA T , Arisawa T, Shibata T, Nakamura M, et al
    Effect of polymorphisms in the 3'-untranslated region (3'-UTR) of VEGF gene on gastric pre-malignant condition.
    Anticancer Res. 2009;29:485-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
36. CARUSO RA , Fedele F, Finocchiaro G, Pizzi G, et al
    Ultrastructural descriptions of pericyte/endothelium peg-socket interdigitations in the microvasculature of human gastric carcinomas.
    Anticancer Res. 2009;29:449-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. TAHARA T , Arisawa T, Shibata T, Yamashita H, et al
    Effect of promoter methylation of multidrug resistance 1 (MDR1) gene in gastric carcinogenesis.
    Anticancer Res. 2009;29:337-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. WU WK , Tse TT, Sung JJ, Li ZJ, et al
    Expression of ErbB receptors and their cognate ligands in gastric and colon cancer cell lines.
    Anticancer Res. 2009;29:229-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
39. CEJKA D , Preusser M, Fuereder T, Sieghart W, et al
    mTOR inhibition sensitizes gastric cancer to alkylating chemotherapy in vivo.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. TURE-OZDEMIR F , Gazouli M, Tzivras M, Panagos C, et al
    Association of polymorphisms of NOD2, TLR4 and CD14 genes with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
41. FUTAWATARI N , Kikuchi S, Sakuramoto S, Kida M, et al
    A new diagnostic method for early gastric cancer: volume measurement by 3-dimensional endoscopic ultrasonography in early gastric cancer and its clinical significance.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. WOLL E , Kuhr T, Eisterer W, Gattringer K, et al
    Biweekly oxaliplatin and irinotecan chemotherapy in advanced gastric cancer. A first-line multicenter phase II trial of the Arbeitsgemeinschaft Medikamentose Tumortherapie (AGMT).
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. OOKI A , Yamashita K, Kikuchi S, Sakuramoto S, et al
    Clinical significance of total gastrectomy for proximal gastric cancer.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
44. KUNISAKI C , Takahashi M, Nagahori Y, Makino H, et al
    Phase I study of biweekly docetaxel and S-1 combination chemotherapy for advanced gastric cancer.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. MIYAGAKI H , Fujitani K, Tsujinaka T, Hirao M, et al
    The significance of gastrectomy in advanced gastric cancer patients with non-curative factors.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. WIKSTEN JP , Lundin J, Nordling S, Kokkola A, et al
    Comparison of the prognostic value of a panel of tissue tumor markers and established clinicopathological factors in patients with gastric cancer.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. ZHENG HC , Zheng YS, Li XH, Takahashi H, et al
    Arp2/3 overexpression contributed to pathogenesis, growth and invasion of gastric carcinoma.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. TOZAWA K , Oshima T, Kobayashi T, Yamamoto N, et al
    Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2008
49. SAKURAI Y , Yoshida I, Kamoshida S, Inaba K, et al
    Changes of gene expression of thymidine phosphorylase, thymidylate synthase, dihydropyrimidine dehydrogenase after the administration of 5'-deoxy-5-fluorouridine, paclitaxel and its combination in human gastric cancer xenografts.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. ISOHATA N , Naritaka Y, Shimakawa T, Asaka S, et al
    Occult lung cancer incidentally found during surgery for esophageal and gastric cancer: a case report.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2008
51. SAKELLARIOU S , Liakakos T, Ghiconti I, Hadjikokolis S, et al
    Immunohistochemical expression of P15 (INK4B) and SMAD4 in advanced gastric cancer.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. LI XH , Zheng HC, Wang ZG, Takahashi H, et al
    The clinicopathological and prognostic significance of MUC-1 expression in Japanese gastric carcinomas: an immunohistochemical study of tissue microarrays.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. CHAN SH , Wu CW, Li AF, Chi CW, et al
    miR-21 microRNA expression in human gastric carcinomas and its clinical association.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. FUJIMOTO D , Hirono Y, Goi T, Katayama K, et al
    Prognostic value of protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1) in gastric cancer.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. WEX T , Ebert MP, Kropf S, Dierkes J, et al
    Gene polymorphisms of the NOD-2/CARD-15 gene and the risk of gastric cancer in Germany.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. TSUJI A , Shima Y, Morita S, Uchida M, et al
    Combination chemotherapy of S-1 and low-dose twice-weekly cisplatin for advanced and recurrent gastric cancer in an outpatient setting: a retrospective study.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. HSU PI , Jwo JJ, Yang CL, Hsu PN, et al
    Association of the myeloperoxidase polymorphism with the risk of gastric cancer.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. KUNISAKI C , Makino H, Takagawa R, Oshima T, et al
    Impact of palliative gastrectomy in patients with incurable advanced gastric cancer.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. HUANG TC , Yeh KH, Cheng AL, Hsu CH, et al
    Weekly 24-hour infusional 5-fluorouracil as initial treatment for advanced gastric cancer with acute disseminated intravascular coagulation.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. NAGASHIMA N , Nakayama Y, Inoue Y, Nagata J, et al
    Prognostic significance of the local expression of interleukin-12 in patients with advanced gastric cancer.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. WOLL E , Devries A, Eisterer W, Hejna M, et al
    Chemotherapy in gastric cancer.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. MIYAGAWA K , Sakakura C, Nakashima S, Yoshikawa T, et al
    Overexpression of RegIV in peritoneal dissemination of gastric cancer and its potential as A novel marker for the detection of peritoneal micrometastasis.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2008
63. YAMASHITA K , Ooki A, Sakuramoto S, Kikuchi S, et al
    Lymph node metastasis density (ND)-factor association with malignant degree and ND40 as "non-curative factor" in gastric cancer.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. KOBAYASHI K , Shida A, Yamada H, Ishibashi Y, et al
    Frequent splicing aberration of the base excision repair gene hMYH in human gastric cancer.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. HSU PI , Lu PJ, Wang EM, Ger LP, et al
    Polymorphisms of death pathway genes FAS and FASL and risk of premalignant gastric lesions.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2007
66. NESI G , Bruno L, Saieva C, Caldini A, et al
    DNA ploidy and S-phase fraction as prognostic factors in surgically resected gastric carcinoma: a 7-year prospective study.
    Anticancer Res. 2007;27.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. YAMASHITA K , Sakuramoto S, Kikuchi S, Katada N, et al
    Surgical resection of stage IV gastric cancer and prognosis.
    Anticancer Res. 2007;27.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. KATSUBE T , Kikuchi T, Konnno S, Murayama M, et al
    Subdural hematoma associated with dural metastasis of gastric carcinoma: report of two cases.
    Anticancer Res. 2007;27.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. HOU L , Grillo P, Zhu ZZ, Lissowska J, et al
    COX1 and COX2 polymorphisms and gastric cancer risk in a Polish population.
    Anticancer Res. 2007;27.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. RUBIO CA , Petersson F, Hoog A, Jonasson JG, et al
    Further studies on serrated neoplasias of the cardia: a review and case report.
    Anticancer Res. 2007;27.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: